CAS: 1380575-43-8 - LDK378 dihydrochloride
Formel:C28H38Cl3N5O3S
- Synonyme:
- 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine,dihydrochloride
- Cs-1407
- W-6134
- LDK-378 dihydrochloride
- 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine hydrochloride
- Ceritinib dihydrochloride
- 5-Chloro-N2-(2-Isopropoxy-5-Methyl-4-(Piperidin-4-Yl)Phenyl)-N4-(2-(Isopropylsulfonyl)Phenyl)Pyrimidine-2,4-Diamine 2Hcl
- LDK378 2Hcl
- 5-chloro-N2-(2-isopropoxy-5-Methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyriMidine-2,4-diaMine hydrochloride
- 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine hydrochloride (1:2)
- Mehr Synonyme anzeigen
2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-, hydrochloride (1:2)
CAS:1380575-43-8
Formel:
C28H38Cl3N5O3S
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
631.0570
Ref: IN-DA0017WX
50mg | 50,00 € | ||
100mg | 63,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 19. November 2024
Ceritinib dihydrochloride
CAS:1380575-43-8
Ceritinib dihydrochloride (LDK378 dihydrochloride) is a selective, orally bioavailable, ATP-competitive inhibitor of ALK tyrosine kinase …
Formel:
C28H38Cl3N5O3S
Reinheit:
99.99%
Farbe und Form:
Solid
Molekulargewicht:
631.06
Ref: TM-T1791L
5mg | 50,00 € | ||
10mg | 63,00 € | ||
25mg | 76,00 € | ||
50mg | 92,00 € | ||
100mg | 122,00 € | ||
1mL*10mM (DMSO) | 66,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 26. November 2024
Ceritinib dihydrochloride
CAS:1380575-43-8
Ceritinib dihydrochloride is a molecule that is used in the treatment of cancer. It inhibits …
Formel:
C28H38Cl3N5O3S
Reinheit:
Min. 95%
Molekulargewicht:
631.06 g/mol
Ref: 3D-FFC57543
100mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 2. Januar 2025